.svg)
%20(1).svg)
%20(14).png)
Discovery & Development US
Hilton San Diego Bayfront
San Diego, CA US
Attend Discovery & Development US event program to learn about the latest advancements in the formulation of large and small molecule-based drugs, developments in RNA, peptide and oligonucleotide design; and explore the innovations in the delivery of complex and challenging therapeutics.
Serán's subject matter expert, Tu Duong, PhD will be on hand to deliver the following presentation:
Beyond Characterization: Turning Early Developability Data Into Drug-Product Decisions
Early developability assessment can do more than characterize the API - it can help define the formulation strategy before extensive development begins. Drawing on Serán’s practical experience, this presentation introduces a decision-oriented approach to:
• Identify API attributes that may constrain drug-product development
• Translate characterization findings into formulation risks and drug-product consequences
• Use mechanistic understanding to prioritize formulation strategies
• Generate targeted, decision-relevant data to accelerate early formulation development
Tu Duong, Ph.D., is a Senior Scientist and Development ProjectLead at Serán Bioscience, an industry-leading drug development partnerproviding a comprehensive range of development and clinical manufacturingservices to pharmaceutical and biotechnology companies. He brings over 10 yearsof broad international experience spanning academic research in Europe and theUnited States, as well as industrial pharmaceutical development. Withrecognized expertise in solid dosage forms and formulation-enablingstrategies—particularly amorphous solid dispersions—he conducted research atPurdue University and earned his Ph.D. in Pharmaceutical Sciences from KULeuven, Belgium. At Serán, he leads development projects focused on earlydevelopability assessment, formulation strategy, and translating complexscientific data into practical drug-product decisions.
Contact us to arrange a meeting
About Serán
Serán BioScience, LLC, is a science-driven drug development partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, email us at hello@seranbio.com.
Contact
Brinette Holdren
Director of Marketing
Serán BioScience, LLC
63047 Layton Ave,
Bend, OR 97701 USA
Phone: (541)-237-8501
www.seranbio.com
